img

Global Pharmaceutical CMO Services Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Pharmaceutical CMO Services Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application

Pharmaceutical CMO Services report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Pharmaceutical CMO Services market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Pharmaceutical Industry and Biotechnology Industry are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Pharmaceutical CMO Services industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Pharmaceutical CMO Services key companies include Lonza, Boehringer Ingelheim, FUJIFILM Diosynth Biotechnologies, AGC Chemicals, AbbVie, Pfizer, Evonik Health Care, Delpharm and Recipharm, etc. Lonza, Boehringer Ingelheim, FUJIFILM Diosynth Biotechnologies are top 3 players and held % share in total in 2022.
Pharmaceutical CMO Services can be divided into Active Pharmaceutical Ingredients (APIs), Finished Dose Formulations (FDFs) and Packaging,, etc. Active Pharmaceutical Ingredients (APIs) is the mainstream product in the market, accounting for % share globally in 2022.
Pharmaceutical CMO Services is widely used in various fields, such as Pharmaceutical Industry and Biotechnology Industry, etc. Pharmaceutical Industry provides greatest supports to the Pharmaceutical CMO Services industry development. In 2022, global % share of Pharmaceutical CMO Services went into Pharmaceutical Industry filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Pharmaceutical CMO Services market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Lonza
Boehringer Ingelheim
FUJIFILM Diosynth Biotechnologies
AGC Chemicals
AbbVie
Pfizer
Evonik Health Care
Delpharm
Recipharm
Teva API
Catalent
Esteve Quimica
Fareva
Patheon
Piramal
Hisun Pharmaceuticals
Segment by Type
Active Pharmaceutical Ingredients (APIs)
Finished Dose Formulations (FDFs)
Packaging

Segment by Application


Pharmaceutical Industry
Biotechnology Industry
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Pharmaceutical CMO Services market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Pharmaceutical CMO Services introduction, etc. Pharmaceutical CMO Services Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Pharmaceutical CMO Services market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of Pharmaceutical CMO Services
1.1 Pharmaceutical CMO Services Market Overview
1.1.1 Pharmaceutical CMO Services Product Scope
1.1.2 Pharmaceutical CMO Services Market Status and Outlook
1.2 Global Pharmaceutical CMO Services Market Size Overview by Region 2024 VS 2022 VS 2034
1.3 Global Pharmaceutical CMO Services Market Size by Region (2024-2034)
1.4 Global Pharmaceutical CMO Services Historic Market Size by Region (2024-2024)
1.5 Global Pharmaceutical CMO Services Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Pharmaceutical CMO Services Market Size (2024-2034)
1.6.1 North America Pharmaceutical CMO Services Market Size (2024-2034)
1.6.2 Europe Pharmaceutical CMO Services Market Size (2024-2034)
1.6.3 Asia-Pacific Pharmaceutical CMO Services Market Size (2024-2034)
1.6.4 Latin America Pharmaceutical CMO Services Market Size (2024-2034)
1.6.5 Middle East & Africa Pharmaceutical CMO Services Market Size (2024-2034)
2 Pharmaceutical CMO Services Market by Type
2.1 Introduction
2.1.1 Active Pharmaceutical Ingredients (APIs)
2.1.2 Finished Dose Formulations (FDFs)
2.1.3 Packaging
2.2 Global Pharmaceutical CMO Services Market Size by Type: 2024 VS 2022 VS 2034
2.2.1 Global Pharmaceutical CMO Services Historic Market Size by Type (2024-2024)
2.2.2 Global Pharmaceutical CMO Services Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Pharmaceutical CMO Services Revenue Breakdown by Type (2024-2034)
2.3.2 Europe Pharmaceutical CMO Services Revenue Breakdown by Type (2024-2034)
2.3.3 Asia-Pacific Pharmaceutical CMO Services Revenue Breakdown by Type (2024-2034)
2.3.4 Latin America Pharmaceutical CMO Services Revenue Breakdown by Type (2024-2034)
2.3.5 Middle East and Africa Pharmaceutical CMO Services Revenue Breakdown by Type (2024-2034)
3 Pharmaceutical CMO Services Market Overview by Application
3.1 Introduction
3.1.1 Pharmaceutical Industry
3.1.2 Biotechnology Industry
3.2 Global Pharmaceutical CMO Services Market Size by Application: 2024 VS 2022 VS 2034
3.2.1 Global Pharmaceutical CMO Services Historic Market Size by Application (2024-2024)
3.2.2 Global Pharmaceutical CMO Services Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Pharmaceutical CMO Services Revenue Breakdown by Application (2024-2034)
3.3.2 Europe Pharmaceutical CMO Services Revenue Breakdown by Application (2024-2034)
3.3.3 Asia-Pacific Pharmaceutical CMO Services Revenue Breakdown by Application (2024-2034)
3.3.4 Latin America Pharmaceutical CMO Services Revenue Breakdown by Application (2024-2034)
3.3.5 Middle East and Africa Pharmaceutical CMO Services Revenue Breakdown by Application (2024-2034)
4 Pharmaceutical CMO Services Competition Analysis by Players
4.1 Global Pharmaceutical CMO Services Market Size by Players (2024-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pharmaceutical CMO Services as of 2022)
4.3 Date of Key Players Enter into Pharmaceutical CMO Services Market
4.4 Global Top Players Pharmaceutical CMO Services Headquarters and Area Served
4.5 Key Players Pharmaceutical CMO Services Product Solution and Service
4.6 Competitive Status
4.6.1 Pharmaceutical CMO Services Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Lonza
5.1.1 Lonza Profile
5.1.2 Lonza Main Business
5.1.3 Lonza Pharmaceutical CMO Services Products, Services and Solutions
5.1.4 Lonza Pharmaceutical CMO Services Revenue (US$ Million) & (2024-2024)
5.1.5 Lonza Recent Developments
5.2 Boehringer Ingelheim
5.2.1 Boehringer Ingelheim Profile
5.2.2 Boehringer Ingelheim Main Business
5.2.3 Boehringer Ingelheim Pharmaceutical CMO Services Products, Services and Solutions
5.2.4 Boehringer Ingelheim Pharmaceutical CMO Services Revenue (US$ Million) & (2024-2024)
5.2.5 Boehringer Ingelheim Recent Developments
5.3 FUJIFILM Diosynth Biotechnologies
5.3.1 FUJIFILM Diosynth Biotechnologies Profile
5.3.2 FUJIFILM Diosynth Biotechnologies Main Business
5.3.3 FUJIFILM Diosynth Biotechnologies Pharmaceutical CMO Services Products, Services and Solutions
5.3.4 FUJIFILM Diosynth Biotechnologies Pharmaceutical CMO Services Revenue (US$ Million) & (2024-2024)
5.3.5 AGC Chemicals Recent Developments
5.4 AGC Chemicals
5.4.1 AGC Chemicals Profile
5.4.2 AGC Chemicals Main Business
5.4.3 AGC Chemicals Pharmaceutical CMO Services Products, Services and Solutions
5.4.4 AGC Chemicals Pharmaceutical CMO Services Revenue (US$ Million) & (2024-2024)
5.4.5 AGC Chemicals Recent Developments
5.5 AbbVie
5.5.1 AbbVie Profile
5.5.2 AbbVie Main Business
5.5.3 AbbVie Pharmaceutical CMO Services Products, Services and Solutions
5.5.4 AbbVie Pharmaceutical CMO Services Revenue (US$ Million) & (2024-2024)
5.5.5 AbbVie Recent Developments
5.6 Pfizer
5.6.1 Pfizer Profile
5.6.2 Pfizer Main Business
5.6.3 Pfizer Pharmaceutical CMO Services Products, Services and Solutions
5.6.4 Pfizer Pharmaceutical CMO Services Revenue (US$ Million) & (2024-2024)
5.6.5 Pfizer Recent Developments
5.7 Evonik Health Care
5.7.1 Evonik Health Care Profile
5.7.2 Evonik Health Care Main Business
5.7.3 Evonik Health Care Pharmaceutical CMO Services Products, Services and Solutions
5.7.4 Evonik Health Care Pharmaceutical CMO Services Revenue (US$ Million) & (2024-2024)
5.7.5 Evonik Health Care Recent Developments
5.8 Delpharm
5.8.1 Delpharm Profile
5.8.2 Delpharm Main Business
5.8.3 Delpharm Pharmaceutical CMO Services Products, Services and Solutions
5.8.4 Delpharm Pharmaceutical CMO Services Revenue (US$ Million) & (2024-2024)
5.8.5 Delpharm Recent Developments
5.9 Recipharm
5.9.1 Recipharm Profile
5.9.2 Recipharm Main Business
5.9.3 Recipharm Pharmaceutical CMO Services Products, Services and Solutions
5.9.4 Recipharm Pharmaceutical CMO Services Revenue (US$ Million) & (2024-2024)
5.9.5 Recipharm Recent Developments
5.10 Teva API
5.10.1 Teva API Profile
5.10.2 Teva API Main Business
5.10.3 Teva API Pharmaceutical CMO Services Products, Services and Solutions
5.10.4 Teva API Pharmaceutical CMO Services Revenue (US$ Million) & (2024-2024)
5.10.5 Teva API Recent Developments
5.11 Catalent
5.11.1 Catalent Profile
5.11.2 Catalent Main Business
5.11.3 Catalent Pharmaceutical CMO Services Products, Services and Solutions
5.11.4 Catalent Pharmaceutical CMO Services Revenue (US$ Million) & (2024-2024)
5.11.5 Catalent Recent Developments
5.12 Esteve Quimica
5.12.1 Esteve Quimica Profile
5.12.2 Esteve Quimica Main Business
5.12.3 Esteve Quimica Pharmaceutical CMO Services Products, Services and Solutions
5.12.4 Esteve Quimica Pharmaceutical CMO Services Revenue (US$ Million) & (2024-2024)
5.12.5 Esteve Quimica Recent Developments
5.13 Fareva
5.13.1 Fareva Profile
5.13.2 Fareva Main Business
5.13.3 Fareva Pharmaceutical CMO Services Products, Services and Solutions
5.13.4 Fareva Pharmaceutical CMO Services Revenue (US$ Million) & (2024-2024)
5.13.5 Fareva Recent Developments
5.14 Patheon
5.14.1 Patheon Profile
5.14.2 Patheon Main Business
5.14.3 Patheon Pharmaceutical CMO Services Products, Services and Solutions
5.14.4 Patheon Pharmaceutical CMO Services Revenue (US$ Million) & (2024-2024)
5.14.5 Patheon Recent Developments
5.15 Piramal
5.15.1 Piramal Profile
5.15.2 Piramal Main Business
5.15.3 Piramal Pharmaceutical CMO Services Products, Services and Solutions
5.15.4 Piramal Pharmaceutical CMO Services Revenue (US$ Million) & (2024-2024)
5.15.5 Piramal Recent Developments
5.16 Hisun Pharmaceuticals
5.16.1 Hisun Pharmaceuticals Profile
5.16.2 Hisun Pharmaceuticals Main Business
5.16.3 Hisun Pharmaceuticals Pharmaceutical CMO Services Products, Services and Solutions
5.16.4 Hisun Pharmaceuticals Pharmaceutical CMO Services Revenue (US$ Million) & (2024-2024)
5.16.5 Hisun Pharmaceuticals Recent Developments
6 North America
6.1 North America Pharmaceutical CMO Services Market Size by Country (2024-2034)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Pharmaceutical CMO Services Market Size by Country (2024-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical CMO Services Market Size by Region (2024-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Pharmaceutical CMO Services Market Size by Country (2024-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical CMO Services Market Size by Country (2024-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Pharmaceutical CMO Services Market Dynamics
11.1 Pharmaceutical CMO Services Industry Trends
11.2 Pharmaceutical CMO Services Market Drivers
11.3 Pharmaceutical CMO Services Market Challenges
11.4 Pharmaceutical CMO Services Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Pharmaceutical CMO Services Market Size (US$ Million) Comparison by Region 2024 VS 2022 VS 2034
Table 2. Global Pharmaceutical CMO Services Market Size by Region (2024-2024) & (US$ Million)
Table 3. Global Pharmaceutical CMO Services Market Size Share by Region (2024-2024)
Table 4. Global Pharmaceutical CMO Services Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Pharmaceutical CMO Services Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Pharmaceutical CMO Services Market Size (US$ Million) by Type: 2024 VS 2022 VS 2034
Table 7. Global Pharmaceutical CMO Services Market Size by Type (2024-2024) & (US$ Million)
Table 8. Global Pharmaceutical CMO Services Revenue Market Share by Type (2024-2024)
Table 9. Global Pharmaceutical CMO Services Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Pharmaceutical CMO Services Revenue Market Share by Type (2024-2034)
Table 11. North America Pharmaceutical CMO Services Revenue by Type (2024-2024) & (US$ Million)
Table 12. North America Pharmaceutical CMO Services Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Pharmaceutical CMO Services Revenue by Type (2024-2024) & (US$ Million)
Table 14. Europe Pharmaceutical CMO Services Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Pharmaceutical CMO Services Revenue by Type (2024-2024) & (US$ Million)
Table 16. Asia-Pacific Pharmaceutical CMO Services Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Pharmaceutical CMO Services Revenue by Type (2024-2024) & (US$ Million)
Table 18. Latin America Pharmaceutical CMO Services Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Pharmaceutical CMO Services Revenue by Type (2024-2024) & (US$ Million)
Table 20. Middle East and Africa Pharmaceutical CMO Services Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Pharmaceutical CMO Services Market Size (US$ Million) by Application: 2024 VS 2022 VS 2034
Table 22. Global Pharmaceutical CMO Services Market Size by Application (2024-2024) & (US$ Million)
Table 23. Global Pharmaceutical CMO Services Revenue Market Share by Application (2024-2024)
Table 24. Global Pharmaceutical CMO Services Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Pharmaceutical CMO Services Revenue Market Share by Application (2024-2034)
Table 26. North America Pharmaceutical CMO Services Revenue by Application (2024-2024) & (US$ Million)
Table 27. North America Pharmaceutical CMO Services Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Pharmaceutical CMO Services Revenue by Application (2024-2024) & (US$ Million)
Table 29. Europe Pharmaceutical CMO Services Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Pharmaceutical CMO Services Revenue by Application (2024-2024) & (US$ Million)
Table 31. Asia-Pacific Pharmaceutical CMO Services Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Pharmaceutical CMO Services Revenue by Application (2024-2024) & (US$ Million)
Table 33. Latin America Pharmaceutical CMO Services Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Pharmaceutical CMO Services Revenue by Application (2024-2024) & (US$ Million)
Table 35. Middle East and Africa Pharmaceutical CMO Services Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Pharmaceutical CMO Services Revenue (US$ Million) by Players (2024-2024)
Table 37. Global Pharmaceutical CMO Services Revenue Market Share by Players (2024-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pharmaceutical CMO Services as of 2022)
Table 39. Date of Key Players Enter into Pharmaceutical CMO Services Market
Table 40. Global Pharmaceutical CMO Services Key Players Headquarters and Area Served
Table 41. Pharmaceutical CMO Services Product Solution and Service
Table 42. Global Pharmaceutical CMO Services Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Lonza Basic Information List
Table 45. Lonza Description and Business Overview
Table 46. Lonza Pharmaceutical CMO Services Products, Services and Solutions
Table 47. Revenue (US$ Million) in Pharmaceutical CMO Services Business of Lonza (2024-2024)
Table 48. Lonza Recent Developments
Table 49. Boehringer Ingelheim Basic Information List
Table 50. Boehringer Ingelheim Description and Business Overview
Table 51. Boehringer Ingelheim Pharmaceutical CMO Services Products, Services and Solutions
Table 52. Revenue (US$ Million) in Pharmaceutical CMO Services Business of Boehringer Ingelheim (2024-2024)
Table 53. Boehringer Ingelheim Recent Developments
Table 54. FUJIFILM Diosynth Biotechnologies Basic Information List
Table 55. FUJIFILM Diosynth Biotechnologies Description and Business Overview
Table 56. FUJIFILM Diosynth Biotechnologies Pharmaceutical CMO Services Products, Services and Solutions
Table 57. Revenue (US$ Million) in Pharmaceutical CMO Services Business of FUJIFILM Diosynth Biotechnologies (2024-2024)
Table 58. FUJIFILM Diosynth Biotechnologies Recent Developments
Table 59. AGC Chemicals Basic Information List
Table 60. AGC Chemicals Description and Business Overview
Table 61. AGC Chemicals Pharmaceutical CMO Services Products, Services and Solutions
Table 62. Revenue (US$ Million) in Pharmaceutical CMO Services Business of AGC Chemicals (2024-2024)
Table 63. AGC Chemicals Recent Developments
Table 64. AbbVie Basic Information List
Table 65. AbbVie Description and Business Overview
Table 66. AbbVie Pharmaceutical CMO Services Products, Services and Solutions
Table 67. Revenue (US$ Million) in Pharmaceutical CMO Services Business of AbbVie (2024-2024)
Table 68. AbbVie Recent Developments
Table 69. Pfizer Basic Information List
Table 70. Pfizer Description and Business Overview
Table 71. Pfizer Pharmaceutical CMO Services Products, Services and Solutions
Table 72. Revenue (US$ Million) in Pharmaceutical CMO Services Business of Pfizer (2024-2024)
Table 73. Pfizer Recent Developments
Table 74. Evonik Health Care Basic Information List
Table 75. Evonik Health Care Description and Business Overview
Table 76. Evonik Health Care Pharmaceutical CMO Services Products, Services and Solutions
Table 77. Revenue (US$ Million) in Pharmaceutical CMO Services Business of Evonik Health Care (2024-2024)
Table 78. Evonik Health Care Recent Developments
Table 79. Delpharm Basic Information List
Table 80. Delpharm Description and Business Overview
Table 81. Delpharm Pharmaceutical CMO Services Products, Services and Solutions
Table 82. Revenue (US$ Million) in Pharmaceutical CMO Services Business of Delpharm (2024-2024)
Table 83. Delpharm Recent Developments
Table 84. Recipharm Basic Information List
Table 85. Recipharm Description and Business Overview
Table 86. Recipharm Pharmaceutical CMO Services Products, Services and Solutions
Table 87. Revenue (US$ Million) in Pharmaceutical CMO Services Business of Recipharm (2024-2024)
Table 88. Recipharm Recent Developments
Table 89. Teva API Basic Information List
Table 90. Teva API Description and Business Overview
Table 91. Teva API Pharmaceutical CMO Services Products, Services and Solutions
Table 92. Revenue (US$ Million) in Pharmaceutical CMO Services Business of Teva API (2024-2024)
Table 93. Teva API Recent Developments
Table 94. Catalent Basic Information List
Table 95. Catalent Description and Business Overview
Table 96. Catalent Pharmaceutical CMO Services Products, Services and Solutions
Table 97. Revenue (US$ Million) in Pharmaceutical CMO Services Business of Catalent (2024-2024)
Table 98. Catalent Recent Developments
Table 99. Esteve Quimica Basic Information List
Table 100. Esteve Quimica Description and Business Overview
Table 101. Esteve Quimica Pharmaceutical CMO Services Products, Services and Solutions
Table 102. Revenue (US$ Million) in Pharmaceutical CMO Services Business of Esteve Quimica (2024-2024)
Table 103. Esteve Quimica Recent Developments
Table 104. Fareva Basic Information List
Table 105. Fareva Description and Business Overview
Table 106. Fareva Pharmaceutical CMO Services Products, Services and Solutions
Table 107. Revenue (US$ Million) in Pharmaceutical CMO Services Business of Fareva (2024-2024)
Table 108. Fareva Recent Developments
Table 109. Patheon Basic Information List
Table 110. Patheon Description and Business Overview
Table 111. Patheon Pharmaceutical CMO Services Products, Services and Solutions
Table 112. Revenue (US$ Million) in Pharmaceutical CMO Services Business of Patheon (2024-2024)
Table 113. Patheon Recent Developments
Table 114. Piramal Basic Information List
Table 115. Piramal Description and Business Overview
Table 116. Piramal Pharmaceutical CMO Services Products, Services and Solutions
Table 117. Revenue (US$ Million) in Pharmaceutical CMO Services Business of Piramal (2024-2024)
Table 118. Piramal Recent Developments
Table 119. Hisun Pharmaceuticals Basic Information List
Table 120. Hisun Pharmaceuticals Description and Business Overview
Table 121. Hisun Pharmaceuticals Pharmaceutical CMO Services Products, Services and Solutions
Table 122. Revenue (US$ Million) in Pharmaceutical CMO Services Business of Hisun Pharmaceuticals (2024-2024)
Table 123. Hisun Pharmaceuticals Recent Developments
Table 124. North America Pharmaceutical CMO Services Market Size by Country (2024-2024) & (US$ Million)
Table 125. North America Pharmaceutical CMO Services Market Size by Country (2024-2034) & (US$ Million)
Table 126. Europe Pharmaceutical CMO Services Market Size by Country (2024-2024) & (US$ Million)
Table 127. Europe Pharmaceutical CMO Services Market Size by Country (2024-2034) & (US$ Million)
Table 128. Asia-Pacific Pharmaceutical CMO Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 129. Asia-Pacific Pharmaceutical CMO Services Market Size by Region (2024-2024) & (US$ Million)
Table 130. Asia-Pacific Pharmaceutical CMO Services Market Size by Region (2024-2034) & (US$ Million)
Table 131. Asia-Pacific Pharmaceutical CMO Services Market Share by Region (2024-2024)
Table 132. Asia-Pacific Pharmaceutical CMO Services Market Share by Region (2024-2034)
Table 133. Latin America Pharmaceutical CMO Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 134. Latin America Pharmaceutical CMO Services Market Size by Country (2024-2024) & (US$ Million)
Table 135. Latin America Pharmaceutical CMO Services Market Size by Country (2024-2034) & (US$ Million)
Table 136. Middle East & Africa Pharmaceutical CMO Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 137. Middle East & Africa Pharmaceutical CMO Services Market Size by Country (2024-2024) & (US$ Million)
Table 138. Middle East & Africa Pharmaceutical CMO Services Market Size by Country (2024-2034) & (US$ Million)
Table 139. Pharmaceutical CMO Services Market Trends
Table 140. Pharmaceutical CMO Services Market Drivers
Table 141. Pharmaceutical CMO Services Market Challenges
Table 142. Pharmaceutical CMO Services Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharmaceutical CMO Services Market Size Year-over-Year 2024-2034 & (US$ Million)
Figure 2. Global Pharmaceutical CMO Services Market Size (US$ Million), 2024 VS 2022 VS 2034
Figure 3. Global Pharmaceutical CMO Services Market Share by Regions: 2022 VS 2034
Figure 4. Global Pharmaceutical CMO Services Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Pharmaceutical CMO Services Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 6. Europe Pharmaceutical CMO Services Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 7. Asia-Pacific Pharmaceutical CMO Services Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 8. Latin America Pharmaceutical CMO Services Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 9. Middle East & Africa Pharmaceutical CMO Services Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 10. Product Picture of Active Pharmaceutical Ingredients (APIs)
Figure 11. Global Active Pharmaceutical Ingredients (APIs) Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 12. Product Picture of Finished Dose Formulations (FDFs)
Figure 13. Global Finished Dose Formulations (FDFs) Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 14. Product Picture of Packaging
Figure 15. Global Packaging Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 16. Global Pharmaceutical CMO Services Market Size Share by Type: 2022 & 2034
Figure 17. North America Pharmaceutical CMO Services Revenue Market Share by Type (2024-2034)
Figure 18. Europe Pharmaceutical CMO Services Revenue Market Share by Type (2024-2034)
Figure 19. Asia-Pacific Pharmaceutical CMO Services Revenue Market Share by Type (2024-2034)
Figure 20. Latin America Pharmaceutical CMO Services Revenue Market Share by Type (2024-2034)
Figure 21. Middle East and Africa Pharmaceutical CMO Services Revenue Market Share by Type (2024-2034)
Figure 22. Pharmaceutical Industry Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 23. Biotechnology Industry Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 24. Global Pharmaceutical CMO Services Market Size Share by Application: 2022 & 2034
Figure 25. North America Pharmaceutical CMO Services Revenue Market Share by Application (2024-2034)
Figure 26. Europe Pharmaceutical CMO Services Revenue Market Share by Application (2024-2034)
Figure 27. Asia-Pacific Pharmaceutical CMO Services Revenue Market Share by Application (2024-2034)
Figure 28. Latin America Pharmaceutical CMO Services Revenue Market Share by Application (2024-2034)
Figure 29. Middle East and Africa Pharmaceutical CMO Services Revenue Market Share by Application (2024-2034)
Figure 30. Pharmaceutical CMO Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 31. Global Top 5 and Top 10 Players Pharmaceutical CMO Services Market Share in 2022
Figure 32. North America Pharmaceutical CMO Services Market Share by Country (2024-2034)
Figure 33. United States Pharmaceutical CMO Services Market Size (2024-2034) & (US$ Million)
Figure 34. Canada Pharmaceutical CMO Services Market Size (2024-2034) & (US$ Million)
Figure 35. Germany Pharmaceutical CMO Services Market Size (2024-2034) & (US$ Million)
Figure 36. France Pharmaceutical CMO Services Market Size (2024-2034) & (US$ Million)
Figure 37. U.K. Pharmaceutical CMO Services Market Size (2024-2034) & (US$ Million)
Figure 38. Italy Pharmaceutical CMO Services Market Size (2024-2034) & (US$ Million)
Figure 39. Russia Pharmaceutical CMO Services Market Size (2024-2034) & (US$ Million)
Figure 40. Nordic Countries Pharmaceutical CMO Services Market Size (2024-2034) & (US$ Million)
Figure 41. Asia-Pacific Pharmaceutical CMO Services Market Share by Region (2024-2034)
Figure 42. China Pharmaceutical CMO Services Market Size (2024-2034) & (US$ Million)
Figure 43. Japan Pharmaceutical CMO Services Market Size (2024-2034) & (US$ Million)
Figure 44. South Korea Pharmaceutical CMO Services Market Size (2024-2034) & (US$ Million)
Figure 45. Southeast Asia Pharmaceutical CMO Services Market Size (2024-2034) & (US$ Million)
Figure 46. India Pharmaceutical CMO Services Market Size (2024-2034) & (US$ Million)
Figure 47. Australia Pharmaceutical CMO Services Market Size (2024-2034) & (US$ Million)
Figure 48. Latin America Pharmaceutical CMO Services Market Share by Country (2024-2034)
Figure 49. Mexico Pharmaceutical CMO Services Market Size (2024-2034) & (US$ Million)
Figure 50. Brazil Pharmaceutical CMO Services Market Size (2024-2034) & (US$ Million)
Figure 51. Middle East & Africa Pharmaceutical CMO Services Market Share by Country (2024-2034)
Figure 52. Turkey Pharmaceutical CMO Services Market Size (2024-2034) & (US$ Million)
Figure 53. Saudi Arabia Pharmaceutical CMO Services Market Size (2024-2034) & (US$ Million)
Figure 54. UAE Pharmaceutical CMO Services Market Size (2024-2034) & (US$ Million)
Figure 55. Bottom-up and Top-down Approaches for This Report